Figure 4.
CCL18 inhibits apoptosis in DU145 cell line. Treated cancer cells with rCCL18 (20 ng/mL) 48 hours. (a) Apoptotic rate of rCCL18-simulated LNCaP cells was not significantly different. (b) However, rCCL18 treatment can significantly suppress the apoptosis of DU145 cells.